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PURPOSE. To investigate fundus autofluorescence (FAF) and other fundus manifestations in
congenital aniridia.
METHODS. Fourteen patients with congenital aniridia and 14 age- and sex-matched healthy
controls were examined. FAF images were obtained with an ultra-widefield scanning laser
ophthalmoscope. FAF intensity was quantified in the macular fovea and in a macular ring
surrounding fovea and related to an internal reference within each image. All aniridia patients
underwent an ophthalmologic examination, including optical coherence tomography and slit-
lamp biomicroscopy.
RESULTS. Mean age was 28.4 6 15.0 years in both the aniridia and control groups. Fovea could
be defined by subjective assessment of FAF images in three aniridia patients (21.4%) and in all
controls (P ¼ 0.001). Mean ratio between FAF intensity in the macular ring and fovea was
1.01 6 0.15 in aniridia versus 1.18 6 0.09 in controls (P ¼ 0.034). In aniridia, presence of
foveal hypoplasia evaluated by biomicroscopy correlated with lack of foveal appearance by
subjective analyses of FAF images (P ¼ 0.031) and observation of nystagmus (P ¼ 0.009).
CONCLUSIONS. Aniridia patients present a lower ratio between FAF intensity in the peripheral
and central macula than do healthy individuals. Both subjective and objective analyses of FAF
images are useful tools in evaluation of foveal hypoplasia in aniridia.
Keywords: aniridia, fundus autofluorescence, macular hypoplasia, optical coherence
tomography, widefield imaging
Aniridia is a rare congenital condition that involves thecornea, anterior chamber angle, iris, lens, retina, and optic
nerve and is often named a panocular disease. In Norway, the
prevalence is 1:76,000.1 Aniridia usually occurs without
obvious systemic involvement but may be part of syndromes.2,3
Iris and foveal hypoplasia are hallmarks present from birth and
commonly result in photophobia, low vision, and nystagmus.
Glaucoma, cataract, and aniridia-associated keratopathy devel-
op in many patients.3,4 Aniridia is inherited in an autosomal
dominant fashion with very high penetrance. Approximately
two thirds of cases are familial, and one third sporadic.5 A
mutation in the PAX6 gene is responsible for development of
the disease in most cases.6
Autofluorescence of the ocular fundus is mainly emitted
from lipofuscin in the retinal pigment epithelium (RPE).7
Lipofuscin accumulates in RPE cells during phagocytosis of the
photoreceptor outer segment. Fundus autofluorescence (FAF)
imaging is a useful noninvasive modality, as in assessment of
achromatopsia8 and prediction of visual prognosis in Stargardt
disease.9 The technique also proved to be helpful in
combination with ultra-widefield fundus imaging.10
The FAF pattern of isolated and aniridic foveal hypoplasia
has been presented in case reports,11–14 but to our knowledge
no systematic case-control study of FAF has been conducted in
aniridia previously nor has any such study described the retinal
appearance by widefield imaging in these patients. Electroret-
inogram recordings, however, showed alterations in the
majority of aniridia subjects.15 Interestingly, rod and cone
function were equally affected. This suggests that not only may
the central retina be affected in aniridia, evident as foveal
hypoplasia,5,16 but the midperipheral and peripheral part may
also be affected.
The Pax6 gene is essential in the embryonic formation of
the eye, including the retina.17As PAX6 is responsible for
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development of aniridia in most cases,18 we hypothesize that
the FAF pattern in aniridia patients differs from that of healthy
individuals. The primary aim of this study was to explore
these differences and to investigate possible correlations
between FAF patterns and presence of foveal hypoplasia
considered by ophthalmoscopy and optical coherence tomog-
raphy (OCT). It is hoped that this will support clinicians in
assessing visual function and prognosis in aniridia. Further-
more, FAF may help understand the disease because of its
utility in evaluation of several types of conditions and
processes in the retina.
Understanding of retinal development and function in
aniridia may also have implications for other eye disorders as
aniridia originates from fundamental disturbances in eye
formation. Moreover, insight into the aniridia phenotype could
be important in monitoring treatment effects as gene therapy
may be an option in the future.19
MATERIALS AND METHODS
This prospective study included 14 aniridia patients, nine of
which were women, and 14 were age- and sex-matched healthy
controls. All participants had similar ethnicity. Patients were
selected from a group of 35 aniridia patients who were
recruited through the patient organization Aniridia Norway.
Inclusion required that the diagnosis of congenital aniridia had
been reported and that it was confirmed through clinical
examination by the presence of typical iris hypoplasia.
Associated ocular conditions could support the diagnosis if
needed. Only individuals ‡9 years of age were included in
order to achieve acceptable OCT images of macula.
All 35 aniridia patients in the original group underwent a
general ophthalmologic examination, including ophthalmosco-
py and OCT, accompanied by classification of aniridia-
associated keratopathy, cataract, and foveal hypoplasia.16,20
Fourteen of the participants were selected in order to obtain
the best-quality fundus photographs. The selection was based
on lowest degree of keratopathy and cataract. To be included,
the stage of keratopathy had to be 2 in both eyes, and total
cataract score had to be 6 in at least one eye. Patients with
pseudophakia or aphakia were allowed to take part, but not if
significant secondary cataract and/or capsular phimosis were
present. Genetic analysis of participants with aniridia was
performed as described by Pedersen et al.16
The study was approved by the Norwegian Regional
Committees for Medical and Health Research Ethics (Applica-
tion 2014/382). After receiving oral and written information
about the study, all participants signed a written informed
consent, as did parents of participants younger than 16 years.
The study was conducted in accordance with the tenets of the
Declaration of Helsinki.
Ophthalmoscopy and Classification of Disease in
Aniridia Group
Eye refraction was determined subjectively as the correction
giving best visual acuity for each eye separately. The refractive
error was defined in diopters (D) by summing the spherical
refractive power and half of the cylindrical power (spherical
equivalent). Accordingly, five groups were defined: emmetro-
pia (refractive error > 0.5 D and < 0.5 D), low-grade
hyperopia (‡ 0.5 D and < 6 D), high-grade hyperopia (‡ 6 D),
low-grade myopia (> 6 D and  0.5 D), and high-grade
myopia (6 D). Visual acuity (logMAR) was measured with a
digital high-contrast chart at 6 m (TestChart 2000; Thomson
Software Solutions, London, UK). Test distance was reduced
to 3 or 1 m if a reliable measurement was unattainable at 6
m.16
The examiner considered presence of nystagmus (yes or
no) while the patient was resting and kept eyes in primary gaze
position. Each subject was further examined in a slit-lamp
biomicroscope. Aniridia-associated keratopathy was staged
according to a previously published classification, which
included four stages (0–3).20 Iris hypoplasia was classified as
total (aplasia) if no iris tissue was visible by slit-lamp
examination or partial if some tissue could be observed.
Cataract was staged in agreement with the Lens Opacities
Classification System III.21
Ophthalmoscopy of the posterior segment was carried out
with a 90-D fundoscopy lens. Foveal hypoplasia was defined as
absence of foveal appearance and/or presence of retinal vessels
traversing the expected foveal area and was considered either
present or not present. Foveal appearance referred to the
typical light reflex and/or darker spot seen by ophthalmoscopy
of central macula. Optic nerve hypoplasia was evaluated based
on the distance from the temporal optic nerve head border to
the foveal center. If the distance was >3.5 times longer than
the horizontal optic nerve head diameter, optic nerve
hypoplasia was considered present. This definition was a
modification built on a study by Barr et al.22 If no definite
foveal center could be determined, then the presence of optic
nerve hypoplasia was stated based on appearance of an
obvious small optic nerve head or a typical double ring sign
around it.
OCT Imaging and Grading of Foveal Hypoplasia in
Aniridia Group
Spectral-domain OCT images of the macula were acquired
(Heidelberg Spectralis OCT2; Heidelberg Engineering GmbH,
Heidelberg, Germany). Volume scans covering a 208 3 208 or
308 3 108 area centered at the expected foveal center were
obtained. Each volume scan consisted of 49 B-scans. Between
5 and 20 frames were averaged in each B-scan to reduce
speckle noise in the image and compensate for eye motion
(TruTrack; Heidelberg Engineering GmbH). If volume scans
could not be achieved because of severe nystagmus, horizontal
line scans with a 308 length were chosen. In these cases, the
scan was moved manually across the macula, using the
temporal edge of the optic nerve head as a reference point.
Multiple scans were captured in the region of the expected
foveal location,23 and signs of foveal specialization were
considered. The ratio between each participant’s axial length
measurement (IOL Master; Carl Zeiss Meditec AG, Jena,
Germany) and the OCT default axial length (24 mm) were
used to correct the lateral image scale for individual retinal
magnification. This ratio was multiplied with the nominal OCT
scan length. Horizontal line scans were divided into retinal
layers, and foveal hypoplasia was graded as described by
Pedersen et al.16
Acquisition and Analysis of Scanning Laser
Ophthalmoscopy Images
Ultra-widefield fundus images were obtained using a scanning
laser ophthalmoscope (Optomap Panoramic 200Tx; Optos
PLC, Dunferlime, Fife, Scotland), which allows nonmydriatic
pictures of up to 2008 of the retina. Photos were also taken of
the central fundus using the central pole function in the
instrument. FAF images were captured with the 532-nm laser
(green-light FAF), and composite color images were acquired
with a combination of the 532- and 633-nm laser. Several
images were obtained in order to avoid influence from
nystagmus, eyelids, and ocular media opacities. All images
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were analyzed by one experienced examiner under similar
conditions.
FAF images were analyzed using ImageJ software (http://
imagej.nih.gov/ij/; provided in the public domain by the
National Institutes of Health, Bethesda, MD, USA). In aniridia
patients, the image with the best quality was chosen for
analysis, and hence only one eye was considered. In control
subjects, one image from both eyes was analyzed and an
average level calculated.
Brightness in the pictures was recorded as mean gray level
(GL), which represented an indirect measure of FAF intensity.
Increasing GL corresponded to elevated brightness in the
picture. In order to reduce sources of error in the analysis, an
internal reference (IRE) was calculated in each image. The IRE
was defined as mean GL in 1000 pixels of the central one third
of the thickest retinal vein from the optic disk margin and
distally (Fig. 1A).
The horizontal distance (foveal distance [FD]) between the
temporal edge of the optic nerve head and the foveal center
was used to define the radius of two concentric circles around
the foveal center (Fig. 1B). The central circle had a radius of
0.36 3 FD pixels and the peripheral circle 0.80 3 FD pixels. If
the foveal center could not be identified in the FAF picture, its
position was estimated based on analysis of the OCT scan.
Mean GL was measured within the central circle (fovea) and in
four segments (upper, lower, nasal, and temporal) of the ring
(macular ring) created between the central and peripheral
circle (Fig. 1C). Shadows from vitreous floaters, cataract, or
keratopathy were outlined manually in the software and
excluded from the measurement.
A ratio was calculated between mean GL in fovea and the
IRE and between mean GL in each of the four macular ring
segments and the IRE. The ratio between mean GL in the
whole macular ring and the IRE was also determined. Finally,
mean GL in the macular ring was divided on mean GL in the
fovea in order to assess the ratio between brightness in these
two areas.
The FAF pictures were classified (yes or no) based on
whether foveal location could be determined by subjective
assessment, defined by ability to localize a hypofluorescent
spot in the expected foveal area (Fig. 2). Peripheral FAF was
graded subjectively as either hypoautofluorescent, normal, or
hyperautofluorescent. Hyperautofluorescence was considered
present if the peripheral FAF was judged as equal to or greater
than FAF of the central fundus. Correspondingly, normal
peripheral FAF indicated FAF regarded as weaker than that of
the central fundus, however clearly identifiable. Hypoauto-
fluorescence referred to peripheral FAF that was difficult to
identify. Equivalently, fundus color images were graded
according to a three-step scale (dark, normal, or light fundus
color).
Statistical Analyses
Statistical analyses were performed with software (SPSS
version 23.0; IBM Corporation, Armonk, NY, USA). Means,
standard deviations, as well as numbers and ratios were used
to describe results of the ophthalmologic examination.
Univariable conditional logistic regression models and McNe-
mar’s test were chosen to compare results from cases and
matched controls. Correlation analyses of parameters in the
aniridia group were performed with univariable logistic
regression and linear regression models and Spearman’s rank
correlation. Results are presented as odds ratio (OR), mean
differences with 95% confidence interval (CI), correlation
coefficients (rs), and P values. P values 0.05 were considered
statistically significant.
FIGURE 1. (A) Outlining of an IRE comprising 1000 pixels of the central
one third of the thickest retinal vein from the optic disk margin and
distally. (B) Two concentric circles around the foveal center defining a
central macular circle (fovea) and a peripheral macular ring (area
between the central and peripheral circle). (C) Division of the macular
ring into four sectors: upper (U), lower (L), nasal (N), and temporal (T).
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RESULTS
Mean age in the aniridia group was 28.4 6 15.0 (range, 11–64)
years and 28.4 6 15.0 (range, 9–64) years in the control group.
Overview of clinical findings and grading of OCT images in the
aniridia group is presented in Table 1. Supplementary Figure S1
shows OCT images from five aniridia patients with foveal
hypoplasia grade 0 to 4. Genetic analysis was available in 12 of
the 14 aniridia patients. PAX6 mutation was detected in eight
of these. Four patients were negative for disease-causing
mutations in PAX6 and the PITX2 and FOXC1 genes. PAX6
mutation was not detected in two of the three subjects without
foveal hypoplasia by ophthalmoscopy. These two had hypo-
plasia grade 0 and grade 1, respectively, assessed by OCT scans.
In the third patient without foveal hypoplasia by ophthalmos-
copy, genetic analysis was not available. This patient had
hypoplasia grade 0 on OCT.
Comparison of FAF Images in Aniridia and Control
Group
Comparison of results in the aniridia and control group is
presented in Table 2. Mean ratio between GL in the fovea and
the IRE was 3.52 6 1.17 in the aniridia group and 3.09 6 0.70
in the control group (OR ¼ 1.48, 95% CI ¼ 0.67–3.27, P ¼
0.334). A similar ratio was determined between mean GL in
each of the four sectors of the macular ring and the IRE. The
ratio was lower in aniridia patients for all four sectors (nasal,
lower, temporal, and upper), but the results were not
statistically significant (Table 2). Finally, the mean ratio
between GL in the whole macular ring and fovea was 1.01 6
0.15 in aniridia and 1.18 6 0.09 in controls (OR¼ 0.001, 95%
CI ¼ 5.42E-07–0.57, P ¼ 0.034). Accordingly, aniridia patients
showed lower difference in autofluorescence intensity be-
tween peripheral and central macula, with a ratio close to 1.
Foveal location could be determined by subjective assess-
ment of autofluorescence pictures in three aniridia patients
(21.4%) and in all control subjects (P¼0.001; McNemar’s test).
Hyperautofluorescence of the peripheral fundus (Fig. 3A) was
established in six aniridia patients (42.9%) and in one control
(7.1%) (OR ¼ 6.00, 95% CI ¼ 0.72–49.8, P ¼ 0.097). All other
participants in both groups showed normal peripheral
autofluorescence (Fig. 3B). The FAF was generally increased
in the whole peripheral fundus of all six patients staged with
FIGURE 2. FAF images of aniridia patients showing (A) a foveal
hypoautofluorescent spot (arrow) and (B) no defined fovea.
TABLE 1. Results From Clinical Examination and Staging of OCT
Images in Aniridia Patients (N¼ 14)
Parameter Result
Visual acuity, logMAR, mean 6 SD 0.69 6 0.29
Refraction, n (%)
Emmetropia 1 (7.1)
Low-grade hyperopia 4 (28.6)
High-grade hyperopia 2 (14.2)
Low-grade myopia 4 (29)
High-grade myopia 3 (21.4)
Nystagmus, n (%) 9 (64)
Stage aniridia-associated keratopathy
Mean stage 6 SD 1.14 6 0.77
Stage 0, n (%) 3 (21.4)
Stage 1, n (%) 6 (42.9)
Stage 2, n (%) 5 (35.7)
Iris aplasia, n (%) 10 (71.4)




Stage of cataract (LOCS III, mean 6 SD)
Nuclear 1.20 6 0.42
Cortical 2.30 6 0.95
Posterior subcapsular 1.20 6 0.42
Papillary hypoplasia, n (%) 4 (29)
Macular hypoplasia (ophthalmoscopy), n (%) 11 (79)
Macular hypoplasia (OCT)
Mean stage 6 SD 2.43 6 1.34
Stage 0, n (%) 2 (14.2)
Stage 1 1 (7.1)
Stage 2 3 (21.4)
Stage 3 5 (35.7)
Stage 4 3 (21.4)
LOCS III, Lens Opacities Classification System III.
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peripheral hyperautofluorescence. However, peripheral hyper-
autofluorescent spots were observed in one of these patients
(Fig. 3A).
Fundus color was considered as light (Fig. 3C, 3D) in 12
aniridia patients, but in only one control (P ¼ 0.001;
McNemar’s test). The remaining participants (one in aniridia
and 11 in control group) had normal fundus color.
Factors Associated With Foveal Hypoplasia in
Aniridia
Presence of foveal hypoplasia by ophthalmoscopy (yes or no)
in the aniridia group was correlated with results from digital
analyses of FAF images and from the ophthalmologic examina-
tion, including subjective assessment of FAF images. Data are
presented graphically in Figure 4A and 4B.
The mean ratio between GL in fovea and the IRE was 3.07
6 1.01(95% CI¼ 0.57–5.57) in patients with normal-appearing
macula by ophthalmoscopy and 3.65 6 1.24 (95% CI ¼ 2.82–
4.48) in those with foveal hypoplasia (Fig. 4A). This numerical
difference indicates that hypoplasia is associated with a more
hyperfluorescent fovea. The mean ratio between GL in the
macular ring and IRE was 3.48 6 1.15 (95% CI¼ 2.71–4.25) in
foveal hypoplasia and 3.73 6 1.01 (95% CI ¼ 1.21–6.24) in
normal-appearing macula, suggesting darker peripheral macula
in hypoplasia. Eventually, the mean ratio between GL in the
macular ring and fovea was compared in the two groups. In
hypoplasia, the ratio was 0.96 6 0.06 (95% CI ¼ 0.91–1.00)
and in those without hypoplasia was 1.23 6 0.19 (95% CI ¼
0.75–1.71). This implies that foveal hypoplasia by ophthalmos-
copy is connected to a lower difference between autofluores-
cence intensity in peripheral and central macula, with a ratio
close to 1.
Foveal location could be determined by subjective analyses
of FAF images in 1 (9.1%) of the 11 patients with foveal
hypoplasia by ophthalmoscopy and in two (66.7%) of the three
subjects with normal macular appearance (Fig. 4B; P¼ 0.031).
Hence, foveal hypoplasia was associated with the lower
possibility of detecting fovea on FAF pictures. In addition,
the sensitivity of subjective FAF analysis in assessment of foveal
hypoplasia was 90.9% (10/11) and the specificity 66.7% (2/3).
Macular pictures were analyzed subjectively in the three
patients without foveal hypoplasia by ophthalmoscopy. In one
of these subjects, it was not possible to identify a clear
hypofluorescent foveal spot on the FAF image. Instead, a
sparse, patchy hypofluorescence was seen in the foveal area. In
the two other patients, the diameter of the hypofluorescent
spot was judged as smaller than that in matched controls.
Moreover, the diameter of the foveal reflex on color images
was considered to be smaller in these two patients than in
control subjects.
Nystagmus was present in 81.8% of patients with foveal
hypoplasia but not in any of those with normal-appearing
macula (Fig. 4B; P¼ 0.009). Four aniridia subjects (36.4%) with
hypoplasia by ophthalmoscopy also had optic nerve hypopla-
sia, but there was none in those with normal macula (P ¼
0.217). All three patients without foveal hypoplasia by
ophthalmoscopy had aniridia-associated keratopathy stage 0.
Patients with hypoplasia had either keratopathy stage 1 or 2
(mean 1.45). One of the patients without hypoplasia was
pseudophakic. The other two had lowest degree (stage 1) of
both nuclear, cortical, and posterior subcapsular cataract. In the
hypoplasia group, the mean stage of nuclear cataract was 1.25;
of cortical cataract, 2.625; and of posterior subcapsular, 1.25.
The mean ratio between GL in the macular ring and the
fovea was calculated in patients with same grade of foveal
hypoplasia on OCT (Fig. 4C). The ratio was 1.25 6 0.27 in
TABLE 2. Comparison of Results From Image Analyses in Aniridia and Control Group
Parameter Aniridia Control OR* 95% CI P Value*
Autofluorescence ratio, mean 6 SD†
Fovea 3.52 6 1.17 3.09 6 0.70 1.48 0.67–3.27 0.334
Macular segment‡
Nasal 3.58 6 1.06 3.80 6 0.88 0.85 0.44–1.64 0.620
Lower 3.51 6 1.19 3.87 6 1.03 0.80 0.44–1.46 0.472
Temporal 3.74 6 1.23 3.85 6 0.96 0.93 0.53–1.66 0.813
Upper 3.30 6 1.07 3.15 6 0.65 1.15 0.55–2.40 0.702
Macular ring 3.53 6 1.09 3.67 6 0.87 0.90 0.47–1.72 0.757
Macular ring/fovea 1.01 6 0.15 1.18 6 0.09 0.001 5.42E-07–0.57 0.034
Fovea defined in FAF images, N (%) 3 (21.4) 14 (100) N/A N/A 0.001§
Peripheral retinal hyperautofluorescence, N (%) 6 (42.9) 1 (7.1) 6 0.72–49.8 0.097
Light fundus color, N (%) 12 (85.7) 1 (7.1) N/A N/A 0.001§
N/A, not applicable because of perfect fit of the outcome.
* Calculated from univariable conditional logistic regression models.
† Ratio between light intensity in retina and IRE (retinal vein).
‡ One fourth of the macular ring around fovea.
§ Performed with McNemar’s test due to perfect distinction between cases and controls.
FIGURE 3. (A) FAF image of an aniridia patient demonstrating
hyperautofluorescence of the peripheral fundus and peripheral hyper-
autofluorescent spots (white arrow). (B) FAF image from aniridia
patient with normal peripheral autofluorescence. (C, D) Examples of
two aniridia patients with light fundus color.
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patients with hypoplasia grade 0 and 1.19 in grade 1. In grade
2, 3, and 4, the mean ratio was 0.96 6 0.07, 0.96 6 0.07, and
0.95 6 0.08, respectively. Consequently, the ratio was
relatively stable above 1 in grade 0 and 1 and under 1 in grade
2, 3, and 4. Linear regression showed that the ratio was
significantly higher in patients with either grade 0 or 1 than in
those with either grade 2, 3, or 4 (P ¼ 0.001).
By subjective assessment of FAF images, a hypofluorescent
spot was identified in the fovea of both participants with
hypoplasia grade 0 on OCT (Fig. 5A, 5B). In the single subject
with hypoplasia grade 1, a patchy hypofluorescent area was
observed in the expected foveal region, but it was not
considered sufficient to determine the foveal location (Fig.
5C). A subtle hypofluorescent spot was noticed in the fovea of
one patient with hypoplasia grade 2 (Fig. 5D). Otherwise, the
foveal location was not possible to identify based on FAF
images in any other participants with either hypoplasia grade 2,
3 (Fig. 5E), or 4 (Fig. 5F). The sensitivity of subjective FAF
analysis in determining foveal hypoplasia by OCT (grade 1, 2, 3,
or 4) was 91.7% (11/12), and the specificity was 100% (2/2).
Additionally, FAF pictures were analyzed subjectively in
order to detect other differences in macula of patients with
various grades of foveal hypoplasia on OCT. Variation was then
observed in the appearance of the retinal vessels. The vessels
in grade 0 and 1 did not manifest any definite abnormalities. In
all patients with hypoplasia grade 2, 3, or 4, however, the
presence of retinal vessels in the peripheral fovea was more
evident than in matched controls. In three out of eight patients
with either hypoplasia grade 3 or 4, the vessels also extended
into or traversed the foveal center (Fig. 5F).
FIGURE 4. (A) Ratios (means with standard deviations) between FAF
intensities in aniridia patients with foveal hypoplasia by ophthalmos-
copy (blue bars) and normal-appearing macula (red bars). (B)
Percentage of patients with foveal hypoplasia and normal macula
who had nystagmus, iris aplasia, papillary hypoplasia, and fovea
determined by subjective assessment of FAF pictures. (C) Ratios
(means with standard deviations) between FAF intensity in peripheral
and central macula in different grades of foveal hypoplasia considered
by OCT. Macular ring, area of peripheral macula around fovea;
reference, IRE in the picture.
FIGURE 5. FAF images of aniridia patients with different grades of
foveal hypoplasia by OCT. (A) Hypoautofluorescence in central macula
(fovea; arrow) in foveal hypoplasia grade 0. (B) Hypoautofluorescent
spot (arrow) present in fovea in hypoplasia grade 0, but less evident
than in A. (C) Patchy hypofluorescent area (arrow) in the expected
foveal region of patient with hypoplasia grade 1. A hyperautofluor-
escent streak (linear degeneration) is evident below the fovea. (D) A
subtle hypofluorescent spot (arrow) in fovea of a patient with
hypoplasia grade 2. (E) Absence of foveal hypoautofluorescence in
hypoplasia grade 3. Foveal center (asterisk) estimated based on OCT
scans. (F) Lack of foveal hypoautofluorescence in hypoplasia grade 4,
including retinal vessel traversing the estimated foveal center
(asterisk).
Fundus Autofluorescence in Aniridia IOVS j October 2019 j Vol. 60 j No. 13 j 4125
Downloaded from iovs.arvojournals.org on 01/09/2020
Among those four aniridia patients with optic nerve
hypoplasia determined by ophthalmoscopy, two had foveal
hypoplasia grade 3 on OCT and the other had two grade 4.
Linear regression demonstrated a significantly higher frequen-
cy of optic nerve hypoplasia in patients with either foveal
hypoplasia grade 3 or 4 than in those with either grade 0, 1, or
2 (P¼ 0.045). This finding indicates coexistence of optic nerve
hypoplasia and the most severe grades of foveal hypoplasia
considered by OCT. No significant differences were found in
FAF between the four patients with both optic nerve
hypoplasia and foveal hypoplasia and the other 10 patients.
Finally, correlation analyses were performed between visual
acuity and results from FAF and OCT analyses in the aniridia
group. Better visual acuity was associated with a higher ratio
between GL in the macular ring and fovea (rs ¼ 0.30).
However, the association was not statistically significant (P ¼
0.299). On the other hand, poorer visual acuity correlated
significantly with increasing grade of foveal hypoplasia on OCT
(rs ¼ 0.73, P ¼ 0.003).
DISCUSSION
Our study showed lack of foveal hypofluorescence in most
aniridia patients (78.6%) by subjective analysis of FAF pictures,
while a hypofluorescent spot could be localized in the foveal
area of all control subjects. This finding corresponded well
with the objective method in which the ratio between
autofluorescence intensity in the peripheral and central
macula was higher in controls than in patients and close to
one in aniridia. Results from the subjective and objective
examination of FAF images were both related to the grade of
foveal hypoplasia evaluated with OCT. Moreover, absence of
foveal demarcation on FAF pictures was associated with
presence of foveal hypoplasia by ophthalmoscopy. Ultra-
widefield color images demonstrated a light fundus in most
aniridia patients (85.7%) but in only one control (7.1%).
In the normal retina, macular fovea appears dark on FAF
pictures. This could be attributed to absorption of excitation
light by macular pigment,7 which has its highest density in the
central fovea.24 Absorption in RPE melanin may also contribute
to reduction in autofluorescence in this area.7 Finally, the
cellular content of lipofuscin is possibly lower in central
macula.25 As foveal hypoplasia is common in aniridia,5
alteration in macular autofluorescence could be expected. In
our study, this was evident as the ratio between FAF intensity in
the peripheral and central macula was lower than in controls.
Additionally, foveal hypoautofluorescence was observed in
only three aniridia patients (21.4%) by subjective analysis of
FAF images, while it was observed in all control subjects. The
ratio between FAF intensity in the peripheral and central
macula was close to 1 in aniridia patients. This suggests an
increase in foveal FAF in aniridia to a level equal to the
peripheral macular fluorescence. It is likely that increased
central macular FAF (or lack of hypofluorescence) could be
ascribed to a reduced amount of macular pigment, since this
substance has its highest concentration in the central fovea.
Theoretically, lower density of RPE melanin could be an
additional explanation for the lack of foveal hypofluorescence
in aniridia.
Absence of a hypofluorescent foveal spot on FAF images
was associated with presence of foveal hypoplasia by
ophthalmoscopy in our study. Additionally, difference in FAF
pattern could be observed between patients with normal
appearing macula by ophthalmoscopy and OCT, and matched,
healthy controls. This included a smaller hypofluorescent
foveal spot in aniridia patients. One patient with normal
macula by ophthalmoscopy and hypoplasia grade 1 on OCT
displayed a sparse, patchy hypofluorescence in the foveal area.
Interestingly, a hypofluorescent spot was present in one
patient with foveal hypoplasia by ophthalmoscopy and
hypoplasia grade 2 on OCT. FAF imaging could therefore be a
useful tool in assessing foveal hypoplasia in aniridia patients
and yield information that cannot be obtained by ophthalmos-
copy or OCT. Scanning laser ophthalmoscopy is easy and quick
to perform, even in small children. The modality is also helpful
in patients with photophobia and nystagmus due to its low
light level. Moreover, widefield imaging provides a valuable
overview of the peripheral fundus. Thus, FAF imaging using
scanning laser ophthalmoscopy could bring clinically relevant
information that is accessible in a wide range of patients.
In all patients presenting foveal hypoplasia by ophthalmos-
copy, macular OCT scans were classified with either hypopla-
sia grade 2, 3, or 4. In the three subjects without hypoplasia by
ophthalmoscopy, two were categorized as grade 0 (normal
configuration) and one as grade 1 on OCT. Accordingly,
assessment of foveal hypoplasia by slit-lamp biomicroscopy
seemed to correspond well with level of macular development
considered by OCT. OCT grading was also related to the ratio
between FAF intensity in the peripheral and central macula. A
significantly higher ratio was detected in hypoplasia grade 0
and 1 than in grade 2, 3, and 4. Consequently, foveal hypoplasia
grade 0 to 1 can be differentiated from grade 2 to 4 by objective
evaluation of FAF images in aniridia patients. Importantly, grade
of foveal hypoplasia on OCT correlated significantly with visual
acuity. However, a significant correlation was not found
between visual acuity and the ratio between FAF in peripheral
and central macula. This indicates that macular OCT is better
than macular FAF to predict visual acuity in aniridia.
Additional information about the grade of foveal hypoplasia
may be achieved by subjective assessment of FAF pictures as
increasing central involvement of vessels in the fovea seemed
to be associated with more advanced grades of hypoplasia
considered with OCT. Consistently, it has been argued that
formation of a foveal depression probably is connected to
development of an avascular zone in the fovea.26 In the current
classification, foveal hypoplasia grade 2 was differentiated from
grade 1 by absence of a foveal depression on OCT. A foveal
depression could be identified by fetal age 25 weeks27 with
increasing depth until postnatal age 15 months.27,28 Simulta-
neously, the foveal cones are maturing.27–29 Thus, foveal
development might have been influenced at the latest from
midgestation in patients with hypoplasia grade 2 and above. A
relation between distribution of macular pigment and size of
the foveal avascular zone and the thickness of the central fovea
has also been found.30 Hence, it could be hypothesized that
macular pigment plays a role in foveal development. It is
possible that the presence of optic nerve hypoplasia could also
be a factor in the process leading to foveal hypoplasia.31 All
patients with optic nerve hypoplasia in our study had either
foveal hypoplasia grade 3 or 4. This finding may support that
optic nerve hypoplasia contributes to more severe foveal
hypoplasia or that these two conditions coincide because of
the genotype.
Fundus color was classified as light in 12 aniridia patients
(86%) but in only one control (7%). Hence, a light or
hypopigmented fundus seems to be a characteristic finding
in aniridia. Few differential diagnoses exist in a patient with
hypopigmented fundus. Among these are oculocutaneous or
ocular albinism and Angelman syndrome.32 Aniridia should
therefore be considered a possible diagnosis in a patient with
hypopigmented fundus. Pax6 is involved in the differentiation
of RPE in embryogenesis of vertebrates.33 It is further shown
that absence of Pax6 reduces production of pigment in RPE
cells. Thus, it is likely that PAX6 mutations in aniridia influence
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RPE cells and explain the presence of a hypopigmented fundus
in most patients.
Aniridia subjects in our study were selected from a larger
group of patients in order to reduce influence from ocular
media opacities on the fundus images. Additionally, the image
with the best quality was chosen for analyses, and hence only
one eye was considered. This might have favored a certain
phenotype. For instance, all patients with normal-appearing
macula by ophthalmoscopy had the lowest degree of aniridia-
associated keratopathy. However, Hingorani et al.5 found foveal
hypoplasia by ophthalmoscopy in 37 of 43 individuals with
aniridia (86%), which is comparable with our results (79%).
Despite selection of participants and the clearest picture for
analyses, aniridia-associated keratopathy and cataract could still
have influenced our findings. Theoretically, different refractive
status and variations in IRE in matched individuals may also
play a role. Mutation in PAX6 was not detected in those two
genetically tested patients without foveal hypoplasia by
ophthalmoscopy. Hence, it seems more likely that these
patients have another gene mutation causing aniridia. Howev-
er, PAX6 mutation was not detected in two patients with foveal
hypoplasia. Additionally, in about 90% of aniridia cases, the
genetic origin could be identified in the PAX6 gene.6 In our
study, analysis of PITX2 and FOXC1 was included as well.
Thus, negative mutational analysis may also be related to lower
detection rate and not only to a specific ocular phenotype.
More comprehensive genetic analysis is required to fully rule
out PAX6 involvement in the cases where no mutation was
found.
Our results showing connection between FAF and foveal
hypoplasia could be useful in further research on congenital
aniridia. For instance, gene therapy has increased packing
density of photoreceptor nuclei in aniridia mice.19 Further-
more, such treatment increased the thickness of all retinal
layers. As distribution of macular pigment is related to central
foveal thickness,30 FAF might be utilized to monitor effects of
gene therapy in aniridia patients in the future. Interestingly,
supplementation of formulas containing macular carotenoids
could improve vision in healthy individuals.34 Such treatment
might be an option in future studies of aniridia, in which any
alterations in FAF should be observed.
In conclusion, our study demonstrates lack of foveal
hypofluorescence on FAF images in most aniridia patients.
Correspondingly, objective image analysis confirms a lower
ratio between peripheral and central macular autofluorescence
in aniridia than in controls. FAF imaging could be a useful tool
in clinical evaluation of aniridia patients as absence of foveal
hypofluorescence correlates well with presence of foveal
hypoplasia. Additionally, FAF imaging can provide information
about macular morphology that is not detectable using
ophthalmoscopy or OCT.
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